[Ip-health] Update: Pegasys patent revoked by IPAB in India

Prathibha Sivasubramanian prathibha.siva at gmail.com
Thu Nov 1 23:25:34 PDT 2012


Dear all,

Today, the Intellectual Property Appellate Board allowed the appeal filed
by Sankalp Rehabilitation Trust, represented by Lawyers Collective HIV/AIDS
Unit, and set aside the patent granted to Roche in India for pegylated
interferon alfa-2a (Pegasys). A detailed update will follow shortly as soon
as we receive a copy of the order.

In solidarity,
Lawyers Collective HIV/AIDS Unit



More information about the Ip-health mailing list